Study: Viagra And Revatio Users 84% More Likely To Develop Melanoma

By Marilyn T. McGoldrick, Esq.

Published on Jun 23, 2014


Recent reports show that the risk of developing melanoma, a potentially fatal skin cancer, is doubled for men who use Viagra® or Revatio®.  Viagra and Revatio (sildenafil), manufactured and distributed by Pfizer, are used to treat erectile dysfunction (ED) and symptoms of pulmonary hypertension. An April 2014 study published in the Journal of the American Medical Association’s JAMAInternal Medicine found that of the nearly 26,000 male participants, those who have used Viagra or Revatio were 84% more likely to develop melanoma versus those who did not use the drug.  The study also pointed out that men who took the drugs weren’t at higher risk of less-dangerous skin cancers, such as basal cell or squamous cell cancers. Rather, use of Viagra or Revatio directly correlated with an increased risk of melanoma.

How we can help

Thornton Law Firm has been a leader in investigating and pursuing compensation for consumers who have been injured by defective drugs and medical devices for more than 30 years. We have a team of attorneys dedicated to this complex area of law. We understand your rights, what is at stake, and how to handle drug claims from beginning to end.  If you have been diagnosed with melanoma after using Viagra or Revatio, or a loved one has been diagnosed with or died from skin cancer after using these drugs, please contact us by telling us your story here, or by calling our toll-free number: 1-888-491-9726.

Contact Us